U.S. markets close in 3 hours 17 minutes
  • S&P 500

    +54.39 (+1.52%)
  • Dow 30

    +472.73 (+1.60%)
  • Nasdaq

    +132.95 (+1.12%)
  • Russell 2000

    +38.75 (+2.13%)
  • Crude Oil

    +1.99 (+4.62%)
  • Gold

    -37.10 (-2.02%)
  • Silver

    -0.41 (-1.75%)

    +0.0024 (+0.20%)
  • 10-Yr Bond

    +0.0280 (+3.27%)

    +0.0010 (+0.08%)

    +0.1600 (+0.15%)

    +702.06 (+3.80%)
  • CMC Crypto 200

    +10.45 (+2.83%)
  • FTSE 100

    +98.33 (+1.55%)
  • Nikkei 225

    +638.22 (+2.50%)

Medical Properties Trust (NYSE:MPW) Has Compensated Shareholders With A Respectable 50% Return On Their Investment

Simply Wall St
·3 min read

It hasn't been the best quarter for Medical Properties Trust, Inc. (NYSE:MPW) shareholders, since the share price has fallen 23% in that time. In contrast the stock is up over the last three years. However, it's unlikely many shareholders are elated with the share price gain of 24% over that time, given the rising market.

Check out our latest analysis for Medical Properties Trust

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

Medical Properties Trust was able to grow its EPS at 0.4% per year over three years, sending the share price higher. This EPS growth is lower than the 7.5% average annual increase in the share price. This indicates that the market is feeling more optimistic on the stock, after the last few years of progress. It is quite common to see investors become enamoured with a business, after a few years of solid progress.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

NYSE:MPW Past and Future Earnings April 20th 2020
NYSE:MPW Past and Future Earnings April 20th 2020

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. This free interactive report on Medical Properties Trust's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Medical Properties Trust, it has a TSR of 50% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!

A Different Perspective

It's nice to see that Medical Properties Trust shareholders have received a total shareholder return of 6.6% over the last year. Of course, that includes the dividend. Having said that, the five-year TSR of 10% a year, is even better. Potential buyers might understandably feel they've missed the opportunity, but it's always possible business is still firing on all cylinders. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with Medical Properties Trust (at least 1 which doesn't sit too well with us) , and understanding them should be part of your investment process.

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.